Dyadic International (DYAI) Restructuring Costs (2024 - 2026)
Dyadic International (DYAI) posted Restructuring Costs of $240009.0 for Q1 2026, up 23.1% sequentially from $194972.0 in Q4 2025, and down 1.43% YoY from $243496.0 in Q1 2025.
Dyadic International (DYAI) Restructuring Costs (2024 - 2026) Analysis & Trends
Dyadic International has reported Restructuring Costs for 3 years, with the latest figure at $240009.0 in Q1 2026.
- Quarterly Restructuring Costs fell 1.43% year-over-year to $240009.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $886525.0 (down 9.76% YoY) and the FY2025 annual result came in at $889987.0, down 10.6% from the prior year.
- Restructuring Costs rose to $240009.0 in Q1 2026 per DYAI's latest filing, from $194972.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $303076.0 in Q2 2024 and troughed at $194972.0 in Q4 2025.
- A 3-year average of $236196.9 and a median of $240009.0 in 2026 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs slipped 17.06% in 2025, then slipped 1.43% in 2026.
- Over 3 years, Restructuring Costs stood at $216823.0 in 2024, then declined by 10.08% to $194972.0 in 2025, then grew by 23.1% to $240009.0 in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $240009.0, $194972.0, and $200165.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Dyadic International | 20.18 Mn | 20.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240,009.00 |
| Dec 31, 2025 | 194,972.00 |
| Sep 30, 2025 | 200,165.00 |
| Jun 30, 2025 | 251,379.00 |
| Mar 31, 2025 | 243,496.00 |
| Dec 31, 2024 | 216,823.00 |
| Sep 30, 2024 | 219,054.00 |
| Jun 30, 2024 | 303,076.00 |
| Mar 31, 2024 | 256,798.00 |